Serum TGF-Beta 1 and TNF-Alpha Levels and Cardiac Fibrosis in Experimental Chronic Renal Failure

References

• Amann, K., Ritzl, E. (2001). The heart in renal failure: morphological changes of the myocardium—new insights. J. Clin. Basic Cardiol. 4:109
   Google Scholar
• Amann, K., Kronenberg, G., Gehlen, F. (1998). Cardiac remodelling in experimental renal failure—an immunohistochemical study. Nephrol. Dial. Transplant. 13:1958–1966. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Avtandilov, N G. (1990). Medical Morphometry Manual. Meditsyna: MoscowRussia, [Russian].
   Google Scholar
• Brilla, C G., Maisch, B. (1994). Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure. Eur. Heart J. 15(Suppl D):45–52. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Bryant, D., Becker, L., Richardson, J. (1998). Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation, 97:1375–1381. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Butt, R P., Laurent, G J., Bishop, J E. (1995). Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur. J. Cell Biol. 68:330–335. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cooper, R S., Simmons, B E., Castaner, A. (1990). Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am. J. Cardiol. 65:441–445., [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cottone, S., Mule, G., Amato, F., Riccobene, R., Vadala, A., Lorito, M C., Raspanti, F., Cerasola, G. (2002). Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure. J. Nephrol. 15(6):643–648. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gavrisheva, N., Yagmurov, O., Botina, A., Emmanuel, V. (2001). Experimental modeling of chronic renal failure. Nephrologiya 5(2):75–78. [Russian]
   Google Scholar
• Grajek, S., Lesiak, M., Pyda, M., Zajac, M., Paradowski, S., Kaczmarek, E. (1993). Hypertrophy or hyperplasia in cardiac muscle. Post-mortem human morphometric analysis. Eur. Heart J. 14:40–47. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Grollier, G., Hurault de Ligny, B., Bonnet, H., Scanu, P., Potier, J C. (1990). So-called uremic heart diseases. Arch. Mal. Coeur Vaiss. 83:401–406. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Henry, R M., Kostense, P J., Bos, G. (2002). Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn study. Kidney Int. 62(4):1402–1407. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kapadia, S., Oral, H., Lee, J. (1997). Hemodynamic regulation of tumor necrosis factor-gene and protein expression in adult feline myocardium. Circ. Res. 81:187–195. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kubota, T., McTiernan, C F., Frye, C S. (1997). Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-β. Circ. Res. 81:627–635. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lijnen, P J., Petrov, V V., Fagard, R H. (2003). Association between transforming growth factor-β and hypertension. Am. J. Hypertens. 16:604–611. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ma, K W., Greene, E L., Raij, L. (1992). Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am. J. Kidney Dis. 19:505–513. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nabel, E G., Shum, L., Pompili, V J. (1993). Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. U. S. A. 90:10759–10763. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Oral, H., Sivasubramanian, N., Dyke, D B., Mehta, R H., Grossman, P M., Briesmiester, K., Fay, W P., Pagani, F D., Bolling, S F., Mann, D L., Starling, M R. (2003). Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation. Circulation 107(6):831–837. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Paul, W E. (1998). Fundamental Immunology. 4th ed. Lippincott, Williams, and Wilkins: Philadelphia.
   Google Scholar
• Peng, H., Carretero, O A., Brigstock, D R., Oja-Tebbe, N., Rhaleb, N. (2003). Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension. Hypertension 42:1164–1170. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rigatto, C., Parfrey, P S. (2001). Uraemic cardiomyopathy: an overload cardiomyopathy. J. Clin. Basic Cardiol. 4:93
   Google Scholar
• Roberts, W. (1885). A Practical Treatise on the Urinary System and Renal Diseases. Smith Elder: London
   Google Scholar
• Rostand, S G., Brunzell, J D., Cannon, R O., Victor, R G. (1991). Cardiovascular complications in renal failure. J. Am. Soc. Nephrol. 2:1053–1062. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Seeland, U., Haeuseler, C., Hinrichs, R., Rosenkranz, S., Pfitzner, T., Scharffetter-Kochanek, K., Bohm, M. (2002). Myocardial fibrosis in transforming growth factor-β(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur. J. Clin. Invest. 32(5):295–303., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sivasubramanian, N., Coker, M L., Kurrelmeyer, K M., MacLellan, W R., DeMayo, F J., Spinale, F G., Mann, D L. (2001). Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor α. Circulation 104:826, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Swynghedauw, B. (). Molecular mechanisms of myocardial remodeling. Physiol. Rev. 1999; 79(1):215–262. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• U.S. Renal Data System. (April 1998). USRDS 1998 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD.
   Google Scholar
• Wahl, S M., Hunt, D A., Wakefield, L M. (1987). Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. U. S. A. 84(16):5788–5792. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wahl, S M., Allen, B J., Weeks, B S., Wong, H L., Klotman, P E. (1993). Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. U. S. A. 90:4577–4581. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Weber, K T. (2000a). Fibrosis and hypertensive heart disease. Curr. Opin. Cardiol. 15:264–272. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Weber, K T. (2000b). Targeting pathological remodeling. Concepts of cardioprotection and reparation. Circulation 102:1342, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2000). 1997–1999 World Health Statistics Annual. Geneva: WHO.
   Google Scholar